FUSOMAB
DEAD

Serial Number

77227864

Owner

Viventia Biotech Inc.

Attorney

WILLIAM F LAWRENCE

Filing Date

Jul 12, 2007

Add to watchlist:

No watchlists yet
View on USPTO

FUSOMAB Trademark

Serial Number: 77227864 • Registration: 4184636

FUSOMAB is a trademark filed by Viventia Biotech Inc. on July 12, 2007. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Viventia Biotech Inc. (14 trademarks)

Suite 405
Mississauga, Ontario L4W 5N5 , CA

Entity Type: 03

VIVENTIA BIOTECHNOLOGIES INC. (10 trademarks)

7895 TRANMERE DRIVE, SUITE 204
MISSISSAUGA, ONTARIO L5S 1V9 , CA

Entity Type: 03

Trademark Details

Filing Date

July 12, 2007

Registration Date

August 7, 2012

Published for Opposition

May 22, 2012

Cancellation Date

March 8, 2019

Goods & Services

Biopharmaceutical preparations and biotechnology preparations for medical purposes for the treatment of malignant and/or benign tumors; cancer; immune diseases, including autoimmune, inflammatory diseases, infectious diseases and vascular diseases; synthetic polypeptides for biopharmaceutical purposes; vaccines; diagnostic preparations for medical purposes; diagnostic preparations, namely, monoclonal antibodies, human antibodies, immune toxins; toxin proteins, and proteins for clinical or medical laboratory use

Biotechnology preparations for commercial purposes, namely, for use in the manufacture of biopharmaceutical and biotechnology products; diagnostic preparations for laboratory and/or medical research purposes; nucleic acids for laboratory use; biological tissue, namely, stem cells for scientific and medical research use; protein arrays for scientific and medical research; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use

Medical and scientific research and development services, namely, preparation and development of proteins and preparation and development services, namely, preparation and development of proteins and preparation and development of in vitro generated recombinant antibodies and proteins, and fragments thereof; product development services for others; preparation and screening of libraries of proteins and antibodies, libraries of cells producing antibodies and proteins, and libraries of vector coding for antibodies and proteins

Filing History

CANCELLED SEC. 8 (6-YR)
Mar 8, 2019 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Aug 7, 2017 REM1
REGISTERED-PRINCIPAL REGISTER
Aug 7, 2012 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 22, 2012 NPUB
PUBLISHED FOR OPPOSITION
May 22, 2012 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 2, 2012 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 16, 2012 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 12, 2012 CNSA
DATA MODIFICATION COMPLETED
Apr 12, 2012 DMCC
EXAMINER'S AMENDMENT ENTERED
Apr 11, 2012 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 11, 2012 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 11, 2012 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 11, 2012 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 4, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 3, 2012 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 3, 2012 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Mar 29, 2012 GNS2
INQUIRY TO SUSPENSION E-MAILED
Mar 29, 2012 GNSI
SUSPENSION INQUIRY WRITTEN
Mar 29, 2012 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Mar 9, 2012 RCCK
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Aug 31, 2011 ASGN
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Aug 23, 2011 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 1, 2011 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 1, 2011 GNSL
SUSPENSION LETTER WRITTEN
Feb 1, 2011 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 11, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 11, 2011 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 11, 2011 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jul 15, 2010 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jul 15, 2010 GNSI
SUSPENSION INQUIRY WRITTEN
Jul 15, 2010 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jun 30, 2010 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Dec 30, 2009 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Dec 4, 2009 RCCK
ASSIGNED TO LIE
Dec 4, 2009 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 22, 2009 GNS3
LETTER OF SUSPENSION E-MAILED
May 22, 2009 GNSL
SUSPENSION LETTER WRITTEN
May 22, 2009 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 27, 2009 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 27, 2009 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 24, 2009 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Oct 30, 2008 GNS2
INQUIRY TO SUSPENSION E-MAILED
Oct 30, 2008 GNSI
SUSPENSION INQUIRY WRITTEN
Oct 30, 2008 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Oct 21, 2008 RCCK
ASSIGNED TO LIE
Oct 21, 2008 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 21, 2008 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 21, 2008 GNSL
SUSPENSION LETTER WRITTEN
Apr 21, 2008 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 25, 2008 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 25, 2008 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 25, 2008 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 23, 2007 GNRN
NON-FINAL ACTION E-MAILED
Oct 23, 2007 GNRT
NON-FINAL ACTION WRITTEN
Oct 23, 2007 CNRT
ASSIGNED TO EXAMINER
Oct 16, 2007 DOCK
NEW APPLICATION ENTERED
Jul 17, 2007 NWAP